News & Updates

In patients hospitalized for severe COVID-19, adding the plant flavonoid quercetin to the antiviral drugs remdesivir or favipiravir reduced hospitalization period and levels of inflammatory markers related to the pathogenesis of SARS-CoV-2, thus preventing the progression of the disease into its critical phase, suggests an open-label study from Iran.

While the strict and rapid implementation of border restrictions, contact tracing, case isolation, social-distancing, and quarantine protocols can effectively suppress COVID-19 transmission, densely populated environments, as in the case of migrant worker dormitories in Singapore, remain at risk of outbreaks, according to a recent study.